Last scanned
Domain Age
Daily Visitors
Global Rank
Updated:
Aeglea BioTherapeutics | Novel Antibody Therapies For IBD
Aeglea combines best-in-class antibody engineering and precision immunology approaches designed to optmize treatments for inflammatory bowel disease (IBD).
This website is hosted with WPEngine, Inc., which reserves the following IP addresses for aegleabio.com: 141.193.213.20, 141.193.213.21. Moreover, DNS used with this website include ns41.domaincontrol.com, ns42.domaincontrol.com. Subnet identifier ranges from 141.193.213.0 to 141.193.213.255. Classless Inter-Domain Routing (CIDR) is 141.193.213.0/24. ARIN net type is Direct Allocation.
Last scanned
Domain Age
Daily Visitors
Global Rank
ns41.domaincontrol.com
ns42.domaincontrol.com
{{value}}
2012-12-07
2023-12-07
Registration Private (Domains By Proxy, LLC)
GODADDY.COM, LLC
{{value}}
The registrar of aegleabio.com is GODADDY.COM, LLC and the name expires on 2023-12-07. Owner email is not available. Their country of residence is United States of America.
686.8K
534
N/A
N/A
N/A
N/A
N/A
N/A
305.1K
320